Clinical Trial: SWOG S1900K

SWOG S1900K

Status: Open

A Randomized Phase II Study of Tepotinib with or Without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)
See Screening Protocol LUNGMAP